AU2002367123B2 - Method and kit for detecting alkaline sphingomyelinase - Google Patents

Method and kit for detecting alkaline sphingomyelinase Download PDF

Info

Publication number
AU2002367123B2
AU2002367123B2 AU2002367123A AU2002367123A AU2002367123B2 AU 2002367123 B2 AU2002367123 B2 AU 2002367123B2 AU 2002367123 A AU2002367123 A AU 2002367123A AU 2002367123 A AU2002367123 A AU 2002367123A AU 2002367123 B2 AU2002367123 B2 AU 2002367123B2
Authority
AU
Australia
Prior art keywords
sample
sphingomyelinase
alkaline
buffer containing
fluorescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002367123A
Other languages
English (en)
Other versions
AU2002367123A1 (en
Inventor
Claudio De Simone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actial Farmaceutica Ltda
Original Assignee
Actial Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Ltda filed Critical Actial Farmaceutica Ltda
Publication of AU2002367123A1 publication Critical patent/AU2002367123A1/en
Application granted granted Critical
Publication of AU2002367123B2 publication Critical patent/AU2002367123B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90206Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/908Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002367123A 2001-12-21 2002-12-19 Method and kit for detecting alkaline sphingomyelinase Ceased AU2002367123B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20011100A IE20011100A1 (en) 2001-12-21 2001-12-21 Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
IE011100 2001-12-21
PCT/IT2002/000811 WO2003056031A2 (en) 2001-12-21 2002-12-19 Method and kit for detecting alkaline sphingomyelinase

Publications (2)

Publication Number Publication Date
AU2002367123A1 AU2002367123A1 (en) 2003-07-15
AU2002367123B2 true AU2002367123B2 (en) 2008-01-10

Family

ID=11042874

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367123A Ceased AU2002367123B2 (en) 2001-12-21 2002-12-19 Method and kit for detecting alkaline sphingomyelinase

Country Status (28)

Country Link
US (3) US20050118152A1 (enExample)
EP (1) EP1456405B1 (enExample)
JP (2) JP2005512601A (enExample)
KR (1) KR101002068B1 (enExample)
CN (1) CN101126716A (enExample)
AR (1) AR038037A1 (enExample)
AT (1) ATE408707T1 (enExample)
AU (1) AU2002367123B2 (enExample)
BR (1) BRPI0215045B1 (enExample)
CA (1) CA2469796C (enExample)
CY (1) CY1108512T1 (enExample)
DE (1) DE60228993D1 (enExample)
DK (1) DK1456405T3 (enExample)
EG (1) EG25804A (enExample)
ES (1) ES2312666T3 (enExample)
HR (1) HRP20040632B1 (enExample)
HU (1) HU228812B1 (enExample)
IE (1) IE20011100A1 (enExample)
IL (2) IL162513A0 (enExample)
MX (1) MXPA04005919A (enExample)
NO (1) NO331806B1 (enExample)
NZ (1) NZ533806A (enExample)
PL (1) PL207876B1 (enExample)
PT (1) PT1456405E (enExample)
RU (1) RU2316002C2 (enExample)
SI (1) SI1456405T1 (enExample)
WO (1) WO2003056031A2 (enExample)
ZA (1) ZA200405762B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20011100A1 (en) 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
PL1973561T3 (pl) * 2005-12-15 2011-08-31 Elanco Us Inc Enzymy do zmniejszania stresu immunologicznego
CN103760348B (zh) * 2014-02-11 2015-03-11 苏州博源医疗科技有限公司 一种甘胆酸免疫检测试剂及其制备和检测方法
CN104614371A (zh) * 2015-02-15 2015-05-13 史春龙 一种在便器中检测排泄物生化指标的方法及使用该方法的检测设备
CN116106281A (zh) * 2023-02-03 2023-05-12 大连医科大学 一种粪便样本中肠道菌脂肪酶活性的检测方法
CN117630364B (zh) * 2023-12-05 2024-07-30 临沂大学 一种双酶型免疫荧光系统检测痕量黄曲霉毒素b1的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
US6265179B1 (en) * 2000-02-01 2001-07-24 Molecular Probes, Inc. Detection of phosphate using coupled enzymatic reactions
IE20011100A1 (en) 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Denisova et al, Free Rad Biol Med, 15 March 2001, 30: 671-678 *
Sofic et al, J Neural Transm, 2001, 108: 541-557 *
Zhang et al, J Biol Chem, 13 April 2001, 276: 11775-117782 *

Also Published As

Publication number Publication date
BRPI0215045B1 (pt) 2015-09-29
PL207876B1 (pl) 2011-02-28
NO20042992L (no) 2004-09-20
BR0215045A (pt) 2004-11-03
US7211410B2 (en) 2007-05-01
CA2469796C (en) 2010-09-14
KR101002068B1 (ko) 2010-12-17
AU2002367123A1 (en) 2003-07-15
US20060141551A1 (en) 2006-06-29
CY1108512T1 (el) 2014-04-09
RU2316002C2 (ru) 2008-01-27
JP2009195239A (ja) 2009-09-03
US7323317B2 (en) 2008-01-29
CN101126716A (zh) 2008-02-20
NO331806B1 (no) 2012-04-10
RU2004122426A (ru) 2005-03-27
NZ533806A (en) 2006-05-26
EP1456405B1 (en) 2008-09-17
HUP0402542A3 (en) 2010-03-29
DE60228993D1 (de) 2008-10-30
IL162513A0 (en) 2005-11-20
PL374085A1 (en) 2005-09-19
DK1456405T3 (da) 2009-01-05
US20070154974A1 (en) 2007-07-05
HUP0402542A2 (hu) 2005-03-29
HRP20040632B1 (hr) 2012-10-31
CA2469796A1 (en) 2003-07-10
ES2312666T3 (es) 2009-03-01
IE20011100A1 (en) 2003-07-09
HK1075069A1 (zh) 2005-12-02
PT1456405E (pt) 2014-01-09
US20050118152A1 (en) 2005-06-02
HRP20040632A2 (en) 2005-04-30
IL162513A (en) 2009-12-24
HU228812B1 (hu) 2013-05-28
KR20040068209A (ko) 2004-07-30
WO2003056031A2 (en) 2003-07-10
AR038037A1 (es) 2004-12-22
JP5009332B2 (ja) 2012-08-22
EG25804A (en) 2012-08-06
ZA200405762B (en) 2006-06-28
WO2003056031A3 (en) 2003-12-18
JP2005512601A (ja) 2005-05-12
EP1456405A2 (en) 2004-09-15
ATE408707T1 (de) 2008-10-15
MXPA04005919A (es) 2004-11-01
SI1456405T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
Merle et al. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson’s disease
US7323317B2 (en) Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
CN113645846B (zh) 检测胃肠道疾病的组合物和方法
JP2009195239A6 (ja) アルカリ性スフィンゴミエリナーゼを検出するための分析方法およびかかる方法に使用するキット
CA2722444C (en) Acetaminophen assay
CN100491540C (zh) 用于检测碱性鞘磷脂酶的试剂盒
US8080375B2 (en) Methods and kits for detecting an enzyme capable of modifying a nucleic acid
JP6989872B2 (ja) 先天性代謝異常症6疾患の同時スクリーニング検査法
Robaszkiewicz et al. Estimation of antioxidant capacity against pathophysiologically relevant oxidants using Pyrogallol Red
HK1075069B (en) Kit for detecting alkaline sphingomyelinase
HK1117906A (en) Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
CN111289456A (zh) 一种检测粪便及肠道组织中肠碱性粒氨酸酶iap的方法
Lee et al. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay
JPH024279B2 (enExample)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired